Literature DB >> 32194054

Chronic Kidney Disease: A Vicarious Relation to Premature Cell Senescence.

Michael S Goligorsky1.   

Abstract

Chronic kidney disease (CKD), commonly fostering nonrenal complications, themselves more life threatening than renal pathology, remains enigmatic. Despite more than a century of intense research, therapeutic options to halt or reverse renal disease are rather limited. Recently, similarity between manifestations of progressive CKD and aging kidney has attracted investigative attention that revealed senescent cells and secreting proinflammatory and profibrotic mediators in all renal compartments, even at young age, in patients with kidney maladies. The overlapping features of these categories have been noticed previously and are briefly summarized herein. I propose two hypothetical scenarios for interactive association of kidney diseases and cell senescence, both culminating in progressive deterioration of renal function. Persistence of senescent cells is considered as a critical contributor to this association; and the mechanisms explaining persistence, such as activation of cell cycle regulators, anti-apoptotic stimuli, metabolic aberrations, and their interactions, are discussed. The mutual encroachment of underlying kidney disease and cell senescence bring about the conclusion that both entities merge along the natural history of the disease. This putative interpretation of vicarious relation between cell senescence and CKD may expand the arsenal of pharmacotherapy to include the judicious use of senotherapeutics in the management of renal disease.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32194054      PMCID: PMC7280755          DOI: 10.1016/j.ajpath.2020.01.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.

Authors:  Wei-Jian Guo; Sonal Datta; Vimla Band; Goberdhan P Dimri
Journal:  Mol Biol Cell       Date:  2006-12-06       Impact factor: 4.138

2.  FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.

Authors:  Samuel K M Li; David K Smith; Wai Ying Leung; Alice M S Cheung; Eric W F Lam; Goberdhan P Dimri; Kwok-Ming Yao
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

Review 3.  Aging, cellular senescence, and cancer.

Authors:  Judith Campisi
Journal:  Annu Rev Physiol       Date:  2012-11-08       Impact factor: 19.318

4.  Anti-Inflamm-Aging Effects of Long-Term Caloric Restriction via Overexpression of SIGIRR to Inhibit NF-κB Signaling Pathway.

Authors:  Xiao-meng Xu; Yi-Chun Ning; Wen-juan Wang; Jie-qiong Liu; Xue-yuan Bai; Xue-feng Sun; Guang-yan Cai; Xiang-mei Chen
Journal:  Cell Physiol Biochem       Date:  2015-10-05

5.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.

Authors:  Remi-Martin Laberge; Yu Sun; Arturo V Orjalo; Christopher K Patil; Adam Freund; Lili Zhou; Samuel C Curran; Albert R Davalos; Kathleen A Wilson-Edell; Su Liu; Chandani Limbad; Marco Demaria; Patrick Li; Gene B Hubbard; Yuji Ikeno; Martin Javors; Pierre-Yves Desprez; Christopher C Benz; Pankaj Kapahi; Peter S Nelson; Judith Campisi
Journal:  Nat Cell Biol       Date:  2015-07-06       Impact factor: 28.824

Review 6.  Small molecule SIRT1 activators for the treatment of aging and age-related diseases.

Authors:  Basil P Hubbard; David A Sinclair
Journal:  Trends Pharmacol Sci       Date:  2014-01-16       Impact factor: 14.819

7.  The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis.

Authors:  Irina M Conboy; Thomas A Rando
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 9.  Cellular senescence in the aging and diseased kidney.

Authors:  F A Valentijn; L L Falke; T Q Nguyen; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2017-12-19       Impact factor: 5.782

Review 10.  Therapeutic Use of mTOR Inhibitors in Renal Diseases: Advances, Drawbacks, and Challenges.

Authors:  Sofia D Viana; Flávio Reis; Rui Alves
Journal:  Oxid Med Cell Longev       Date:  2018-10-29       Impact factor: 6.543

View more
  7 in total

Review 1.  Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.

Authors:  Jie Xu; Lili Zhou; Youhua Liu
Journal:  Front Pharmacol       Date:  2020-12-11       Impact factor: 5.810

Review 2.  Cellular Senescence in Renal and Urinary Tract Disorders.

Authors:  Yohan Santin; Philippe Lluel; Pascal Rischmann; Xavier Gamé; Jeanne Mialet-Perez; Angelo Parini
Journal:  Cells       Date:  2020-11-05       Impact factor: 6.600

Review 3.  Radiation-induced kidney toxicity: molecular and cellular pathogenesis.

Authors:  Richard Klaus; Maximilian Niyazi; Bärbel Lange-Sperandio
Journal:  Radiat Oncol       Date:  2021-02-25       Impact factor: 3.481

Review 4.  The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity.

Authors:  Jing-Li Zhao; Xiao-Hui Qiao; Jian-Hua Mao; Fei Liu; Hai-Dong Fu
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

Review 5.  Cellular senescence in ischemia/reperfusion injury.

Authors:  Chaojin Chen; Muxu Zheng; Hongbiao Hou; Sijian Fang; Liubing Chen; Jing Yang; Weifeng Yao; Qi Zhang; Ziqing Hei
Journal:  Cell Death Discov       Date:  2022-10-18

Review 6.  Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration.

Authors:  Alessandra Tammaro; Jesper Kers; Angelique M L Scantlebery; Sandrine Florquin
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

Review 7.  Klotho, Aging, and the Failing Kidney.

Authors:  Sarah Buchanan; Emilie Combet; Peter Stenvinkel; Paul G Shiels
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-27       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.